Dec 5, 2024CONTRACTHungary, Hungary Sharps Technology signs sales agreements for SecureGard syringes with European medical supply company
Sharps Technology has signed multiple sales agreements with a prominent European medical supply company to sell its SecureGard syringe inventory. Initial shipments and revenue began in early December 2024, with new production orders starting in Q2 2025.
ProductsSecureGard safety syringes
“The execution of this five-year Sales Agreement creates a manufacturing demand for at least 500 million syringes and completely sells out the currently available manufacturing capacity for Sharps’ 10mL SoloGard syringes.”nasdaq.com
- 4 sources
- nasdaq.comSharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue | NasdaqDec 5, 2024
- biopharmawatch.comSharps Technology's CEO Issues Shareholder Letter HighlightingBiopharmaWatch ResearchDec 5, 2024
- theglobeandmail.comSharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard - The Globe and MailSharps Technology IncDec 5, 2024
- globenewswire.com
Summarized from public sources; check the original articles before acting on it.
ENDATA